United States
Germany
Japan
United Kingdom
China
AAV6 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
Others
AAV3 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
AAV6 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAV2 control particles, shRNA scramble, expressing GFP and puro, >10^13 GC/mL, 2 x 50 ul
AAV3 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAV7 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 2 x 50 ul
AAV7 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAVDJ with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
